跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 19,658 条关于
“Neurophet AQUA AD Plus”
全部
19,658
临床试验
14,336
药物
931
机构
282
资讯
4,109
7个月前
Neurophet Receives Third FDA 510(k) Clearance for AI-Powered Alzheimer's Imaging Analysis Software
去年
Advanced Emollient Plus Formulation Shows Superior Efficacy in Atopic Dermatitis Treatment
10个月前
Aqua Medical Receives FDA IDE Approval for Breakthrough Endoscopic Type 2 Diabetes Treatment
上个月
Aqua Medical Advances PIMA Procedure for Type 2 Diabetes with First West Coast Patient and New CEO
去年
Sanofi Aims to Expand Atopic Dermatitis Market Presence with Novel Therapies
去年
Formycon's Aflibercept Biosimilar, AHZANTIVE®/Baiama®, Receives Positive CHMP Opinion for EU Approval
去年
Acumen's Sabirnetug Shows Promise in Phase 1 Alzheimer's Trial
去年
PSM Challenges Hims & Hers' Super Bowl Ad for Compounded Semaglutide
去年
UCB Showcases Promising Neurodegenerative Disease Research at AD/PD 2025
去年
Rocatinlimab Shows Significant SCORAD Improvement in Atopic Dermatitis Phase 2b Trial
第 1 页,共 411 页
上一页
下一页